Join The Discussion

 

Moves by Jeb Bush add to talk of 2016 candidacy

WASHINGTON — Jeb Bush's decision to release a policy-laden e-book and all his emails from his time as governor of Florida has further stoked expectations among his allies that he will launch a presidential bid.

read more >

Ebby Halliday acquires Fort Worth’s Williams Trew

Williams Trew Real Estate of Fort Worth has been acquired by Dallas-based residential real estate brokerage Ebby Halliday Real Estate Inc.

read more >

Meridian Bank Texas parent acquired by UMB Financial for $182.5M

Kansas City, Mo.-based UMB Financial Corp., the parent company of UMB Bank, said Dec. 15 it has signed a definitive agreement to acquire Marquette Financial Companies in an all-stock transaction.

read more >

Cousins Properties to sell 777 Main tower in downtown Fort Worth

Cousins Properties Inc. has confirmed plans to sell the 777 Main office tower in downtown Fort Worth, according to a news release from the Atlanta-based real estate investment firm.

read more >

Glen Garden sale closes, distillery on tap

Firestone & Robertson Distilling Co. closed late Wednesday on its purchase of the historic Glen Garden Country Club in southeast Fort Worth, with plans to convert it into a whiskey distillery and bucolic visitor attraction.

read more >

Alcon to lose about 120 research jobs in Novartis consolidation
By Bill Bowen
Novartis said it will consolidate its pharmaceutical eye-disease research projects in Cambridge, Mass., moving about 120 jobs out of Alcon Labs in Fort Worth that are part of the Novartis Institutes for BioMedical Research.
The move reflects a new strategic direction for the pharmaceutical company’s glaucoma and ocular inflammation research effort and still leaves about 950 jobs in the Alcon Research and Development operations in Fort Worth.
Cambridge is also the headquarters for the Novartis Institutes for BioMedical Research and the shift puts the entire effort in one spot, according to company officials.
“That’s where NIBR’s headquarters is and the NIBR drug discovery will be together,” said Alcon spokesman Dave Jackson said. Novartis has about 1,600 scientists in Cambridge, Jackson said.
The Alcon operations that remain are part of the Alcon Research and Development, which focuses on drug and device research and development will continue to operate with a full workforce, the company said.
Novartis, based in Basel, Switzerland, finished its acquisition of Nestle’s stake in Alcon in 2011 and the Novartis research unit has been based in Fort Worth for the past two years, Jackson said. Novartis has 119,000 employees and operates in 140 countries. It enjoyed sales of more than $50 billion in 2012.
Alcon began in 1945 as a Fort Worth pharmacy specializing in eye products. Novartis paid more than $50 billion for Alcon altogether. Alcon enjoyed sales of about $10.2 billion in 2012.
bbowen@bizpress.net

< back

Email   email
hide
TCU/Baylor
Did the College Football Playoff Committee get it right?